Shionogi & Co., Ltd. - Notice of Revision of Results Forecast for the Year Ended March 31, 2007

TOKYO, April 4, 2007-Shionogi & Co., Ltd. has revised its results forecast for the fiscal year ended March 31, 2007, which was announced on November 6, 2006, as follows.

1. Revised Results Forecast for the Full Fiscal Year

April 1, 2006 – March 31, 2007
Consolidated

(Millions of yen)

Net sales Operating income Ordinary income Net income
Original forecast (A)

 205,000

31,000

31,000

18,000

Revised forecast (B)

200,000

28,500

28,000

18,000

Increase (decrease) (B-A)

 (5,000)

 (2,500)

 (3,000)

-

Percentage increase (decrease)

 (2.4?)

(8.1?)

 (9.7?)

 -

Previous fiscal year

196,388

29,226

 29,656

22,735

(2) Non-consolidated

(Millions of yen)

Net sales Operating income Ordinary income Net income
Original forecast (A)

193,000

27,500

29,000

17,000

Revised forecast (B)

185,500

24,500

25,500

17,000

Increase (decrease) (B-A)

 (7,500)

 (3,000)

 (3,500)

-

Percentage increase (decrease)

 (3.9?)

(10.9?)

 (12.1?)

 -

Previous fiscal year

183,388

25,770

28,107

26,663


2. Reasons for the Revisions

Net sales for the year ended March 31, 2007 are projected to fall short of the original forecast due to weaker sales of core ethical drugs resulting from lower prevalence of influenza and pollen allergies and the delay of the planned sales expansion of new products. Consequently, both operating income and ordinary income are forecast to be below the original forecast. Net income is expected to meet the original forecast due to gain on exchange of shares that was not included in the original non-consolidated forecast.

For Further Information

Shionogi & Co., Ltd., Public Relations Unit

Osaka TEL: +81-6-6209-7885 FAX: +81-6-6229-9596

Tokyo TEL: +81-3-3406-8164 FAX: +81-3-3406-8099

Posted: April 2007


View comments

Hide
(web2)